Cysteinyl leukotrienes as common mediators of asthma and allergic disease

This publication has 27 references indexed in Scilit:

• Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall
  Annals of Allergy, Asthma & Immunology, 2002
• Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis
  Clinical and Experimental Allergy, 2001
• Effects of monotherapy with intra‐nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis
  Clinical and Experimental Allergy, 2001
• Allergic rhinitis: not purely a histamine‐related disease
  Allergy, 2000
• Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of “one linked airway disease”
  Annals of Allergy, Asthma & Immunology, 2000
• Urinary excretion of inflammatory mediators during allergen‐induced early and late phase asthmatic reactions
  Clinical and Experimental Allergy, 1998
• Effect of leukotriene D₄ on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans
  Clinical and Experimental Allergy, 1986
• Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to Ragweed
  New England Journal of Medicine, 1984
• Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.
  Proceedings of the National Academy of Sciences, 1981
• Biological profile of Ieukotrienes C₄ and D₄
  Acta Physiologica Scandinavica, 1980